No data to
display.
Tracon Pharmaceuticals, Inc. posted profit of 1,170 K revenue of 7,498 K
Published on Jul 30, 2022 | 02:30 AM IST
Tracon Pharmaceuticals, Inc. [TCON]
As of Nov 07, 2017| Source: Quarterly Report to the SEC
We are a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing our cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States.
| Industry | Manufacturing |
| Revenue | 7,498 K |
| Profits | 1,170 K |